A BCG Challenge Model Study to Assess Anti-mycobacterial Immunity Induced by BCG and a Candidate TB Vaccine, MVA85A

NCT01194180 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis

Interventions

BIOLOGICAL: BCG: 100 microlitres ~ 2-8 x 105 pfu
BIOLOGICAL: MVA85A: 1 x 108 pfu BCG: 100 microlitres ~ 2-8 x 105 pfu

Sponsor

University of Oxford